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Introduction. Resistance to antibiotics and presence of virulence 
factors play an important role in increased mortality associated 
with infection due to Staphylococcus aureus. In this study, we 
determine antibiotic resistance pattern, presence of the icaADBC 
locus as well as biofilm formation and distribution and diversity 
the immune evasion cluster (IEC) genes in clinical isolate of S. 
aureus from Kerman, Iran.
Materials and methods. During 15 months, 100 clinical isolates 
S. aureus recovered from different patients were admitted to Ker-
man University affiliated hospitals. Resistance to different antibi-
otic agents was determined by disk diffusion method. Phenotypic 
method was used to the determination of biofilm formation ability 
and methicillin-resistance S. aureus (MRSA). Polymerase chain 
reaction technique (PCR) was used to the detection of nuc, mecA, 
icaA, icaD, icaB, icaC, scn, sea, sak, sep and chp genes.. 
Results. Forty-four isolates were considered as MRSA and all of 
isolates were sensitive to vancomycin and linezolid. Our results 
showed, 77.2% (34/44) of MRSA and 8.9 % (5/56) of MSSA iso-
lates were multidrug resistant. The predominant IEC variant was 
type B and our results displayed that 77.7% of the MRSA isolates 
harbor loci icaD and mecA. There was no significant difference in 
production biofilm between MSSA and MRSA isolates (P ≥ 0.05). 
There was significant difference in presence IEC types between 
MSSA and MRSA isolates (P = 0.000).
Conclusions. The presence of icaADBC locus may not be a deter-
mining factor for biofilm formation in Staphtlocooci and other 
mechanisms might be involved in this process.The high prevalence 
IEC types in MSSA isolates can indicate that the presence of these 
genes can be an advantage for pathogenesis of these isolates in 
different infections. 
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Introduction
Staphylococcus aureus is both a commensal and a ver-
satile human pathogen causing a broad spectrum of 
disease, from mild skin and soft tissue infections to 
life-threatening sepsis, pneumonia, endocarditis and 
deep-seated abscesses [1, 2]. The emergence of methi-
cillin-resistant strains as well as having multiple viru-
lence factors are the main factors in increased mortal-
ity in hospital–acquired (HA) and community-acquired 
(CA) infections caused by S. aureus [3]. Recent studies 
have displayed an increase in the worldwide prevalence 
of MRSA. In a regional perspective, a higher prevalence 
of MRSA in Iran compared to neighboring countries 
in the Middle East, except Iraq has been reported [4]. 
One study which reported HA-MRSA rates for eight 
Asian countries showed higher percentage of MRSA in 
those countries compared to Iran. Mean prevalence of 
MRSA in Iran is moderately higher than Australia and 
lower than the United States  [5]. However, recent re-
ports have revealed that MRSA rates are decreasing in 
United States [6]. This organism produces a number of 
virulence factors that provide the ability to colonize for 
it, adhere to surfaces as biofilm, invade or evade the im-
mune system, develop resistance to multiple antibiotics 
and cause toxicity to the host [7, 8]. The ability of S .au-
reus to produce an extracellular slime and constitutive a 
biofilm enables this organism to withstand the host im-
mune response and to make clinical treatment extremely 
difficult because of biofilm creation protects bacteria 
from antimicrobial agent [9]. The intracellular adhesion 
(ica) cluster, icaADB and C, encodes enzymes mediat-
ing cell-cell the adhesion and synthesis of the polysac-
charide intercellular adhesion (PIA) which is essential 
for biofilm establishment [10, 11]. Another attribute of 
S. aureus which enables the pathogen’s escape from pro-
tective immune responses express a number of immune-
modulating proteins  [12]. One of the immune-modu-
lating proteins is staphylococcal complement inhibitor 
(SCIN). SCIN is a complement inhibitor, blocking the 
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ability of human neutrophils to opsonophagocytose of 
S. aureus and neutrophil chemotaxis [13, 14]. The gene 
encoding SCIN (scn) was found to be portion of a so-
called immune evasion cluster (IEC). All IEC variants 
harbor scn and a different combination of sak, chp and 
sea (or sep). So far seven different variants of IEC car-
ried by several different βC-Фs[14, 15]. These encode 
the human-specific immune modulators including staph-
ylococcal enterotoxin A (SEA), staphylokinase (SAK) 
and chemotaxis inhibitory protein of S. aureus (CHIPS). 
SEA is involved in the down-regulation of chemokine 
receptors of monocytes [16]. SAK is a bacterial plas-
minogen activator and blocker, the bactericidal effect of 
antimicrobial peptides, the α-defensins [17]. CHIPS can 
bind to the formylated peptide receptor and neutrophils 
so can block neutrophil chemotaxis [18, 19].
To our knowledge, there is no information about preva-
lence of IEC-carrying βC-Фs in human   S. aureus isolates 
in Iran. Since different studies have shown the decisive 
role of the ica genes as virulence factors in staphylococcal 
infections [20, 21] and IECs are bacteriophage encoded, 
the aim of this study was to determine antibiotic resist-
ance pattern, the biofilm formation ability, the presence 
of the icaADBC locus and investigate the distribution and 
diversity the immune evasion cluster (IEC) genes among 
clinical isolate of S. aureus from Kerman, Iran.
Materials and methods
Bacterial isolates
A total of 100 non repetitive clinical isolates of S. au-
reus recovered from different patients, were admitted 
to Kerman University affiliated hospitals during Febru-
ary 2015 to May 2016. Clinical samples such as urine, 
blood, discharged abscess, wound, cerebrospinal fluid 
(CSF), broncoalveolar (BAL), synovial fluid and pus 
were included in this study. Bacterial isolates were con-
sidered as S. aureus by conventional biochemical stan-
dard methods including Gram-staining, catalase, slide 
and tube coagulase, DNase and maninitol fermentation 
on mannitol salt agar medium. All the applied culture 
media were purchased from Merck, Germany. The final 
identification of S. aureus isolates was done by amplifi-
cation of nuc gene in species level in PCR method [22].
We defined ‘community acquired (CA)’ and ‘healthcare 
associated infections or hospitalized patients (HA)’ ac-
cording to the current CDC criteria [23].
Susceptibility of isolates to antibiotics
The disk diffusion method on Müller-Hinton agar medi-
um (MHA) was used to determine susceptibility of iso-
lates to ciprofloxacin (5µg), trimethoprim/sulfamethox-
azole (1.25/23.75µg), gentamicin (10µg), amikacin 
(30µg), erythromycin (15µg), clindamycin (2µg), tetra-
cycline (30µg) and linezolid (30µg) (Mast disks,UK) ac-
cording to guidelines of Clinical Laboratory Standards 
Institute (CLSI) [24]. The Brain Heart Infusion (BHI) 
agar medium with 6 µg/ml vancomycin used for screen-
ing of vancomycin resistant S. aureus isolates (VRSA). 
S. aureus ATCC 25923 was used as standard strain in 
susceptibility tests to antibiotics. Multidrug resistance 
(MDR) was defined as resistance of isolate to three or 
more unique antimicrobial drug classes in addition to 
beta-lactams [25].
Screening of methicillin-resistant S. aureuS 
isolates (MRSA)
The MRSA isolates were detected by susceptibility of 
isolates to cefoxitin (FOX: 30 µg) on MHA according to 
recommendations of the CLSI [24] and then confirmed 
for the presence of mecA gene by PCR technique as 
described previously [26]. Patients who have acquired 
CA-MRSA infections did not have typical MRSA risk 
factors such as recent history of hospitalization, kidney 
dialysis, residence in a long-term health care facility or 
intravenous drug use.
Biofilm formation 
S. aureus isolates were cultured on Trypticase Soy Agar 
(TSA) at 37ºC for 24h. Few grown colonies suspended 
in sterile physiological saline with turbidity equal to 
0.5McFarland. The 96 well polystyrene microtiter pla-
tessterile (Cell and Tissue Culture plates, flat well bot-
tom, Guangzhou Jet Bio-Filtration Products Co., Ltd. 
Guangdong, China) were filled with 180µl Trypticase 
Soy Broth (TSB) supplemented with 1% glucose and 
20µl of bacterial suspension added to each well. After 
incubation for 24h at 37ºC, broth was carefully drawn 
off and the plates were gently washed three times with 
sterile phosphate-buffered saline (PBS). The plates were 
inverted and allowed to dry for 1 hour at room tempera-
ture. For biofilm quantification, 200µl of 2% saffranin 
dye solution in water was added to each well and the 
plates were allowed to stand for 40 min at room temper-
ature. The wells were subsequently washed thrice with 
sterile PBS to wash off the excess saffranin. Saffranin 
bound to the biofilm was extracted with 200ml of 95% 
ethanol, and the absorbance of the extracted saffranin 
was measured at 490 nm in an ELISA reader (BioTek, 
USA). Each assay was performed in triplicate. As a 
negative control, TSB+1%glucose medium was used to 
determine background optical density (OD). The cut-off 
ODc for biofilm formation was determined as average 
OD of negative control +3×standard deviation (SD) of 
negative control. OD value was calculated for each mi-
crotiter plate separately. OD > 4×ODc was considered as 
high biofilm formation ability; 2×ODc < OD ≤ 4×ODc 
categorized into moderate biofilm formation ability. 
ODc < OD ≤ 2×ODc and OD ≤ ODc were taken as weak 
or none biofilm formation ability respectively [27].
DNA extraction
Deoxyribonucleic acid (DNA) extraction was performed 
by using appropriate DNA extraction kit (Gene All, Ko-
rea) following manufacturer’s instruction. The quality 
of isolated DNA was measured by determination of ab-
sorbency at the wave length A260 nm and 280nm that 
showed a high quality of the product.
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Detection of ICA and IEC cluster genes  
by PCR
Amplification was conducted in temperature gradient 
thermal cycler (Biometra-T300, Gottingen, Germany) in 
a volume of 25µl. Each 25µl PCR mixture consisted of 
1µl of bacterial DNA, 0.5 µl (10pM) of each oligodeoxy-
nucleotide primers, 12.5 µl of 2× Master Mix Red (Am-
pliqon, Denmark) and 11µl DNase and RNase free wa-
ter. PCR was used for detection nuc, mecA, icaA, icaD, 
icaB ,icaC ,scn, sea, sak, sep, chb genes. All primers and 
programs can be found in Table I [14, 18, 26, 28-30]. 
After amplification, the PCR products were analyzed by 
electrophoresis on 1.5% agarose gel in 0.5×TBE buffer 
(5.4 g Tris base, 2.75 g boric acid, 2 ml 0.5 M EDTA, 
in 1 L). DNA ladder was a ready to use plasmid double 
digest sized range 100- 3000bp obtained from SMOBIO 
Technology (Hsinchu, Taiwan). Specificity of the prim-
ers was checked by Primer Quest software tool (http://
www.ncbi.nlm.nih.gov/GenBank).
Statistical analysis
Statistical analysis was performed with SPSS (v.22.0) 
statistics software. We used the Chi-Square test for the 
comparison of our data. A difference was considered sta-
tistically significant at a P-value of < 0.05.
Results
A total of 100 S. aureus isolates were obtained from 
80 in patients (HA) and 20 outpatients (CA) with dif-
ferent clinical infections. The isolates corresponded to 
61 males and 39 females. Most of the clinical isolates 
belonged to urine 30% (n = 30) followed by wound 28% 
(n = 28), blood 22% (n = 22), BAL 7% (n = 7), CSF 
3% (n = 3), skin abscesses, synovial fluid, pus and other 
clinical samples 10 %( n = 10). Of the 100 S. aureus 
isolates, 44 (44%) were MRSA which were recovered 
from urine (n = 22, 50%), wound (n = 9, 20.4%), blood 
(n = 4, 9.1%), BAL (n = 4, 9.1%), CSF (n =1, 2.3%) and 
pus (n = 3, 7%) samples. Among the MRSA isolates, 
68.2 %(n  =  30) were classified as hospital-acquired 
MRSA (HA-MRSA) and 31.8% (n = 14) as community-
acquired MRSA (CA-MRSA). 
Antimicrobial susceptibility testing and PCR 
results
The resistance profiles of MRSA and MSSA isolates to 
antimicrobial agents tested were listed in Table II. All of 
isolates were sensitive to vancomycin and linezolid.  It 
was found that 93.2% (n = 41) and 86.3 %( n = 38) of 
MRSA isolates were resistant to erythromycin and tetra-
cycline respectively. In addition, the highest resistance 
MSSA isolates was to trimethoprim/sulfamethoxazole 
30.4% (n = 17) and tetracycline 28.6 %( n = 16). The 
resistance rates of MRSA isolates to amikacin, cipro-
floxacin, clindamycin, erythromycin, gentamicin and 
tetracycline were significantly higher than among MS-
SA isolates (Table II). Three CA-MRSA isolates had in-
termediate (borderline) resistance to clindamycin, while 
19 MSSA isolates had intermediate (borderline) resis-
tance as follows: 3(5.3%) to ciprofloxacin, 6(10.7%) to 
clindamycin and 10 (17.9%) to erythromycin. Overall, 
77.2% (34/44) of MRSA isolates and 8.9%( 5/56) of 
MSSA were multidrug resistant (MDR). HA–MRSA 
isolates were more resistant to multiple antibacterial 
classes than CA-MRSA isolates (73.5% vs. 26.5%). Fif-
ty (50%) isolates contained an IEC-converting (βC-Фs), 
Tab. I. PCR primers and cycling parameters for genes presented in this study.
Gene 
target




































1 min 95 ºC,45 sec 61 ºC,1min 72 ºC 483 [53]
mecA
F-TCC AGA TTA CAA CTT CAC CAG G
R-CCA CTT CAT ATC TTG TAA CG




1 min 95 ºC,45 sec 60 ºC,1min 72 ºC 279 [30]
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as demonstrated by the presence of scn. The predomi-
nant IEC variant was type B (sak, chp and scn) present 
in 20 (40%) of 50 clinical isolates. Variant A (sea, sak, 
chp and scn), C (chp and scn), D (sea, sak and scn), E 
(sak and scn), F (sep, sak, chp, scn), and G (sep, sak and 
scn) were present in 2 (4%), 5 (10%), 3 (6%), 14 (28%), 
3 (6%) and 0 (0%) of the fifty clinical isolates, respec-
tively. Three isolates have both scn and sea which were 
non type able and negative mecA (Tab. III). Concerning 
the virulence factors in all isolates, chp was present in 36 
(36%), sak was in 60 (60%), and the super antigens sea 
and sep were in 10 (10%) and 3 (3%) respectively. scn 
was present in 54% of these isolates.There was signifi-
cant difference in presence of IEC types between MSSA 
and MRSA isolates (P = 0.000) (Tab. III).
Biofilm formation
The ability to produce biofilm in 9 (9%) isolates was 
strong, 26 (26%) isolates was moderate, 48 (48%) iso-
lates was weak and 17 (17%) of them had no production 
biofilm. The prevalence of icaA, icaB, icaC and icaD in 
all of isolates was 2%, 1%, 2% and 84% respectively. 
Only in one MSSA isolate, all ica genes were positive 
and biofilm was strong. There was no significant differ-
ence in production biofilm between MSSA and MRSA 
isolates (P ≥ 0.05). Although 69 of 84 (82.1%) produc-
ing biofilm isolates were positive for icaD, no signifi-
cance difference between the presence of icaD gene and 
biofilm production was observed (P ≥ 0.05).Thirty four 
MRSA was icaD gene positive.
Discussion
S. aureus is a powerful pathogen that is able to grow 
in nearly any part of the human body. This bacterium 
remains the most frequent cause of hospital and com-
munity-acquired infections with the high prevalence and 
rapid spread of drug-resistant S. aureus strains. S.  au-
reus generates biofilm and an array of immune evasion 
factors that protect it from innate immune defense sys-
tem [31]. According to the results of this study, 44% of 
isolates recognized as MRSA, were positive for mecA 
gene. A  study conducted by Javan et al. [32] reported 
42.6 % frequency of MRSA in Tehran. However, the 
frequency of MRSA isolates in present study is more 
than the results of some previous reports published from 
Iran and some other countries [33-36].The estimated 
prevalence in our study was lower than that found in 
the studies of Khosravi et al. [37], Heidari et al.  [38], 
Sepehriseresht et al. [39], Saderi et al. [40] and Gudarsi 
et al. [25]. A systematic review displayed that prevalence 
of MRSA in Iran is high and varies between 20.4% and 
90% in different parts of the country [41]. Discrepancy 
in MRSA prevalence may reflect differences in infection 
control policies, origin of the isolates and the character-
istics of the participants and hospital wards [25]. Rapid 
and correct determination of the different S. aureus iso-
lated from patients is a major help in understanding the 
epidemiology of this bacteria and its infection control.
The full susceptibility of MRSA and MSSA isolates re-
covered from clinical samples to vancomycin and line-
zolid observed in this study, is possibly as a consequence 
of limited usage of these antimicrobial agents and indi-
cates that these antimicrobial agents are effective for the 
treatment of S. aureus infections in our population. Our 
data are in agreement with susceptibility rates in Iran 
and other countries [40-43].
Majority of the MRSA were resistant to tetracycline and 
erythromycin and these resistance patterns have been 
documented already by another study [43]. In view of the 
high resistance rates of MRSA to gentamicin, clindamy-
cin, tetracycline, ciprofloxacin and erythromycin anti-
biotics which are probably due to misuse and overuse 
of these antibiotics, display that empirical treatment of 
MRSA infections at our hospitals with these may not 
be effective. Hence, these antibacterial agents should no 
longer be considered first-line drugs for the treatment of 
MRSA infections in our population.Our study revealed 
that 30.4% of MSSA and 47.7% of MRSA isolates were 
resistant to trimethoprim/sulfamethoxazole. In contrast 
of our data, several studies have been reported low rates 
of resistance to trimethoprim/sulfamethoxazole in S. au-
reus isolates [25, 45]. Our data is not in agreement with 
study by Wanget al [46] who reported trimethoprim-sul-
famethoxazole susceptibility rates of 78.6% and 95.3% 
for MRSA and MSSA isolates respectively, recovered 
from patients in 12 cities across China.
Tab. II. Antimicrobial profiles of MRSA (HA-MRSA and CA-MRSA) and MSSA isolates from 100 patients of Kerman University affiliated hospitals.
Type of isolates
Rate of resistance to antimicrobial agents. n(%)
Isolates. n(%) AK GM CD E CIP T SXT
CA-MRSA 14 (14%) 3 (6.8) 6 (13.6) 9 (13.6) 14 (31.8) 6 (13.6) 11 (25) 6 (13.6)
HA-MRSA 30 (30%) 21 (47.7) 25 (57) 20 (45.5) 27 (61.4) 25 (57) 27 (61.4) 15 (34.1)
MSSA 56 (56%) 1 (1.8) 2 (3.6) 2 (3.6) 11 (19.6) 8 (14.3) 16 (28.6) 17 (30.4)
Total 100 (100) 25 (25) 33 (33) 31 (31) 52 (52) 39 (39) 54 (54) 38 (38)
AK; Amikacin, GM; Gentamicin, CD; Clindamycin, E; Erythromycin, CIP; Ciprofloxacin, T; Tetracycline, SXT; trimethoprim/sulfamethoxazole,





No. of IEC types 
A B C D E F G
MSSA 39 (69.6) 2 19 5 2 11 - -
MRSA 8 (18.2) - 1 - 1 3 3 -
Total 47 (47%) 2 20 5 3 14 3 -
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In this study, 77.2% of MRSA isolates were multidrug 
resistant, and this is of concern. Our results emphasize 
the need for persistent monitoring of antimicrobial resis-
tance development in S. aureus isolates that are involved 
in hospital-acquired infections.
MSSA isolates exhibited intermediate resistance to cip-
rofloxacin, clindamycin and erythromycin, sug gesting 
that more isolates can become resistant in the near future 
and the possible antimicrobial therapies for infections 
associated with such staphylococcal strains are confined.
Presence of staphylococci, especially those strains which 
generate an extracellular slime and constitute a biofilm, 
making clinical treatment extremely difficult [47]. Our 
results displayed that 77.7% of the MRSA isolates har-
bor locus icaD and mecA gene. Frebourg et al [48] have 
demonstrated that a large proportion of clinical isolates 
carrying the ica locus also harbor the mecA gene. Simi-
lar results have been reported by Martin-Lopez et al [47] 
and mirzaee et al [49]. We noted that 7 MRSA and 5 
MSSA isolates were ica genes negative and biofilm pro-
ducers and that 5 MRSA and 10 MSSA isolates were 
icaA positive and biofilm negative. In this regard our 
data may support some published data based on that bio-
film formation may rely on environmentally regulated, 
icaADBC-independent mechanism(s) in MRSA [50, 51]. 
Eftekhar et al.  [52, 53] showed that biofilm formation 
is independent of the icaADBC carriage in clinical and 
skin isolates of S. epidermidis. In contrast, namvar [54] 
reported that S. aureus isolates had no ability to form 
biofilm, unless they were positive for icaD gene. Re-
lationship between the biofilm formation and the pres-
ence of these ica genes has been demonstrated in other 
studies [55, 56]. From clinical viewpoint, explanation of 
the main adhesive mechanisms in infections may help 
in developing preventive and therapeutic criterions, such 
as antiadhesive coatings or antiadhesin medicines [28].
In the present study, we demonstrated that 50% clini-
cal S. aureus isolates contained an IEC-carrying bac-
teriophage. The predominant IEC variant was type B 
which has reported as the predominant variant in human 
infectious isolates [14]. Immune evasion cluster (IEC) 
is known to playan important role in human coloniza-
tion [15]. To our knowledge, this study is the first report 
of prevalence Immune Evasion Cluster (IEC) genes in 
clinical isolates of S. aureus in Iran.
One study has shown that 90% of the human clinical S. 
aureus strains from a genetically diverse collection con-
tain an IEC-carrying βC-Фs [14]. Some studies have dem-
onstrated that the high incidence of IEC- carrying βC-Фs 
compared to other mobile elements carrying virulence 
factors such as eta, lukS-PV/lukFPV which are also car-
ried by bacteriophages in human S.aureus strains, is a 
unique feature [57, 58]. One major reason for this obser-
vation is probably due to ability IEC to carrying by several 
different phages so they can cover a huge host range. IEC 
has spread successfully through the S. aureus population 
and will continue to do so. This enables S. aureus with a 
unique mechanism to adapt to, and counteract, the human 
host [14].On the one hand knowledge of the virulence 
strategies can help choose new ways to combat staphy-
lococcal infections. On the other hand identification viru-
lence genes provides potential targets in the treatment of 
S. aureus infection. For example the potent capacityof 
CHIPS to inhibit neutrophil chemotaxis, in vitro and in-
vivo, makes this  protein a promising candidate anti-in-
flammatory drug for those diseases in which C5a-induced 
damage by neutrophils plays an essential role [18].
In conclusion,this study reports that there was no corre-
lation between antibiotic resistance and biofilm forma-
tion in under study clinical isolates of S. aureus and the 
biofilm formation ability of several MRSA and MSSA 
isolates in the absence of icaABCD genes suggests that 
further investigation is necessary to better under stand 
ica-independent biofilm formation mechanisms. Dif-
ferent IEC types were detected among the isolates but 
these types were absent in many MRSA isolates.The 
high prevalenceIEC types in MSSA isolates can indicate 
that the presence of these genes can be an advantage for 
pathogenesis of these isolates in different infections.
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